Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that the European Commission (EC) has granted marketing authorisation in the
Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd announced that the Committee for Medicinal Products for Human Use (CHMP)
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd ( announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevn (bevacizumab-nwgd), a biosimilar
Fuel up with free Health Tech Insights
